Minerva Neurosciences, Inc. (NERV)

2.32 +0.08 (+3.57%) USD  |  NASDAQ  |  Oct 30, 16:00
2.30 -0.02 (-0.86%) After-Hours: 20:00
More

Minerva Neurosciences EPS Estimates for Current Fiscal Year

EPS Estimates for Current Fiscal Year Chart

View EPS Estimates for Current Fiscal Year for NERV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS Estimates for Current Fiscal Year Data

View and export this data back to 2024. Start Trial.
Date Value
August 10, 2026 --
May 18, 2026 --
May 11, 2026 --
March 12, 2026 --
November 06, 2025 --
Date Value
February 26, 2025 --
November 06, 2024 --
August 07, 2024 --
May 02, 2024 --
February 23, 2024 --

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for Current Fiscal Year Range, Past 5 Years

View EPS Estimates for Current Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Estimates for Current Fiscal Year Benchmarks

View EPS Estimates for Current Fiscal Year Benchmarks
Start Trial
Heron Therapeutics, Inc. Upgrade
Tonix Pharmaceuticals Holding Corp. Upgrade
Karyopharm Therapeutics, Inc. Upgrade
Corbus Pharmaceuticals Holdings, Inc. Upgrade
Ocugen, Inc. Upgrade

EPS Estimates for Current Fiscal Year Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Next Fiscal Year Upgrade